Dutasteride/Tamsulosin (Jalyn) for Benign Prostatic Hyperplasia

被引：0
|
作者：
Wilson, Stephen A. [1 ]
Broders, Jennie [1 ]
机构：
[1] Univ Pittsburgh Family Med Residency, Pittsburgh, PA USA
来源：
AMERICAN FAMILY PHYSICIAN | 2012年 / 85卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1194 / 1195
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia
    Tsukamoto, Taiji
    Endo, Yukihiro
    Narita, Michiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (09) : 745 - 750
  • [42] Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
    Drugs & Therapy Perspectives, 2008, 24 (7) : 5 - 9
  • [43] Abnormal ejaculation associated with tamsulosin in benign prostatic hyperplasia patients
    Naruganahalli, Krishna S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (12) : 1635 - 1638
  • [44] Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia
    Duan, Yinghui
    Grady, James J.
    Albertsen, Peter C.
    Wu, Z. Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (03) : 340 - 348
  • [45] Tamsulosin Versus Terazosin for Benign Prostatic Hyperplasia: A Systematic Review
    Dong, ZhiLong
    Wang, ZhiPing
    Yang, KeHu
    Liu, YaLi
    Gao, WenHui
    Chen, WenYuan
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2009, 55 (04) : 129 - 136
  • [46] Effects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia
    Choi, Jae Hwi
    Hwa, Jung Seog
    Kam, Sung Chul
    Jeh, Seong Uk
    Hyun, Jae Seog
    WORLD JOURNAL OF MENS HEALTH, 2014, 32 (02): : 99 - 104
  • [47] Evaluation of Safety and Efficacy of Alfuzosin and Tamsulosin in Benign Prostatic Hyperplasia
    Praveen, R.
    Kumar, T. N.
    Sen
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S119 - S120
  • [48] Tamsulosin and floppy iris syndrome in benign prostatic hyperplasia patients
    Tiwari, A
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) : 443 - 446
  • [49] Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men
    Haque, Nazneen
    Masumori, Naoya
    Sakamoto, Sadaaki
    Ye, Zhangqun
    Yoon, Sang-Jin
    Kuo, Hann-Chorng
    Brotherton, Betsy
    Wilson, Timothy
    Muganurmath, Chandra
    McLaughlin, Megan
    Manyak, Michael
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (11) : 944 - 951
  • [50] Cost-effectiveness of dutasteride in the treatment of benign prostatic hyperplasia (BPH)
    Kaczor, M.
    Pawlik, D.
    Becla, L.
    Dardzinski, W.
    Jasinska, A.
    Wojcik, R.
    Walczak, J.
    Nogas, G.
    Cel, M.
    Glogowski, C.
    Zespol-Instytutu, A.
    VALUE IN HEALTH, 2006, 9 (06) : A253 - A254
12345